Women and men with coronary artery disease (CAD) differ in their presenting
symptoms, baseline risk factors, age, and body size. These differences acc
ount for most of the previously reported differences in the management of w
omen with CAD. When using larger databases and adjusting for confounding fa
ctors, women increasingly resemble men in terms of the care they receive an
d their outcomes. We reviewed recent articles on the pharmacologic and surg
ical management of women with CAD. Although women and men with CAD should b
e treated similarly, physicians still must recognize the sometimes atypical
presentation of CAD in women and be mindful of the smaller body size of wo
men regarding drug dosing and revascularization.